<DOC>
	<DOCNO>NCT01201044</DOCNO>
	<brief_summary>The purpose study investigate efficacy BAI Plus 3DCRT local advance NSCLC .</brief_summary>
	<brief_title>Study Investigate Bronchial Arterrial Infusing ( BAI ) Plus Three-dimensional Conformal Radiotherapy ( 3DCRT ) Local Advanced Non-small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<criteria>stage IIIA &amp; IIIB NSCLC male female , Age ≥18Years , ≤70Years Life expectation least 12weeks . PS performance 02 Measurable disease accord Response Evaluation Criteria Solid Tumours ( RECIST ) Patient prior chemotherapy radiology IIIA IIIB NSCLC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>BAI</keyword>
	<keyword>3DCRT</keyword>
</DOC>